NYSE:BIOLife Sciences
Bio-Rad Laboratories (BIO): Assessing Valuation Following Q3 Loss and Share Buyback Completion
Bio-Rad Laboratories (BIO) released its third-quarter financial results, posting a net loss compared to a sizeable profit this time last year. The company also completed a major share repurchase initiative during the quarter, adding another dimension for investors to consider.
See our latest analysis for Bio-Rad Laboratories.
Despite the challenging quarterly results and the latest share buyback, Bio-Rad Laboratories’ share price has shown a bit of a rebound recently, with an 11.9% share...